In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination.

In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination.

Item
http://www.wikidata.org/entity/Q37218996
Development of test panel of beta-lactamases expressed in a common Escherichia coli host background for evaluation of new beta-lactam antibioticsIn vitro activities of ampicillin-sulbactam and cefoperazone-sulbactam against oxacillin-susceptible and oxacillin-resistant staphylococci.In vitro activities of cefoperazone and sulbactam singly and in combination against cefoperazone-resistant members of the family Enterobacteriaceae and nonfermenters.Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis.Clinical epidemiology and molecular analysis of extended-spectrum-β-lactamase-producing Escherichia coli in Nepal: characteristics of sequence types 131 and 648Use of a predictor panel for development of a new disk for diffusion tests with cefoperazone-sulbactam.First identification of OXA-72 carbapenemase from Acinetobacter pittii in Colombia.Criteria for disk susceptibility tests and quality control guidelines for the cefoperazone-sulbactam combination.Multiple-dose pharmacokinetics and toleration of intravenously administered cefoperazone and sulbactam when given as single agents or in combination.Antibacterial effect evaluation of moxalactam against extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae with in vitro pharmacokinetics/pharmacodynamics simulation.Genetic characterization and in vitro activity of antimicrobial combinations of multidrug-resistant Acinetobacter baumannii from a general hospital in China.
P2860

In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination.

Item
http://www.wikidata.org/entity/Q37218996
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 1987
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vitro antimicrobial spectru ...... erazone-sulbactam combination.
@en
In vitro antimicrobial spectru ...... erazone-sulbactam combination.
@nl
type
label
In vitro antimicrobial spectru ...... erazone-sulbactam combination.
@en
In vitro antimicrobial spectru ...... erazone-sulbactam combination.
@nl
prefLabel
In vitro antimicrobial spectru ...... erazone-sulbactam combination.
@en
In vitro antimicrobial spectru ...... erazone-sulbactam combination.
@nl
P1433
P1476
P2093
P2860
P304
P31
P407
P433
P478
P577
P698
P932
P1433
P1476
In vitro antimicrobial spectru ...... perazone-sulbactam combination
@en
P2093
P2860
P304
P31
P407
P433
P478
P577
P698
P932